Krystal Biotech Stock (NASDAQ: KRYS) stock price, news, charts, stock research, profile.
Open | $176.490 |
Close | - |
Volume / Avg. | 212.527K / 393.844K |
Day Range | 175.920 - 180.240 |
52 Wk Range | 77.095 - 189.970 |
Market Cap | $5.013B |
P/E Ratio | 453.949 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 65 |
Short Interest | 10.15% |
Days to Cover | 8.01 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Krystal Biotech (NASDAQ: KRYS) through any online brokerage.
Other companies in Krystal Biotech’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), Ionis Pharmaceuticals (NASDAQ:IONS), Cerevel Therapeutics Hldg (NASDAQ:CERE) and Alkermes (NASDAQ:ALKS).
The latest price target for Krystal Biotech (NASDAQ: KRYS) was reported by Citigroup on Tuesday, February 27, 2024. The analyst firm set a price target for 195.00 expecting KRYS to rise to within 12 months (a possible 9.31% upside). 21 analyst firms have reported ratings in the last year.
The stock price for Krystal Biotech (NASDAQ: KRYS) is $178.39 last updated Today at March 28, 2024 at 3:22 PM EDT.
There are no upcoming dividends for Krystal Biotech.
Krystal Biotech’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Krystal Biotech.
Krystal Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.